|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
One Broadway 14th Floor, Cambridge, Massachusetts 02142, US
|
|
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive NSCLC, along with multiple discovery-stage research programs. To learn more, visit www.nuvalent.com.
|
Nuvalent, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Nuvalent, Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Nuvalent, Inc. customer service number in your country click here to find.
James Porter is the CEO of Nuvalent, Inc..
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.